News
CMS proposes improved E/M payments, additional price transparency for hospitals
July 29, 2019
The Medicare Outpatient Prospective Payment System proposed rule for the 2020 annual update would require hospitals to publish the negotiated price by specific payer for select services that patients can schedule in advance.
![1]()
News
FDA approvals permit double-immunoassay approach to Lyme disease diagnosis
July 29, 2019
The streamlined approach to diagnosis may speed treatment of Lyme disease.
![1]()
News
Most patients with new hypertension under revised BP guidelines won’t need pharmacotherapy
July 29, 2019
ORLANDO – In terms of nonpharmacologic therapies for these patients, the largest benefit is in getting them to lose weight.
![1]()
News
Gram-negative bacteremia: Cultures, drugs, and duration
July 29, 2019
Management of gram-negative bacteremia remains a challenging clinical situation for inpatient providers.
News
Beyond C. difficile: The future of fecal microbial transplantation
July 29, 2019
SAN DIEGO – Future directions for microbial transplantation range from multifactorial and functional gut disorders to consideration of the small intestinal microbiome.
![1]()
News
Older adults’ interested in conversations about deprescribing
July 29, 2019
Among older adults, what attitudes exist toward deprescribing?
![1]()
News
Trained interpreters essential for treating non–English-speaking patients
July 28, 2019
NEW YORK – Even in a private office setting, failure to engage a trained translator is discouraged.
![1]()
News
As patients, physicians fare nearly the same as everyone else
July 27, 2019
Physicians do only slightly better than nonphysicians in adhering to guidelines, “but not by much and not always.”
![1]()
News
NSAID use in high-risk patients not linked with short-term, safety-related adverse event
July 26, 2019
In patients with hypertension, chronic kidney disease, or heart failure presenting with a musculoskeletal disorder, how frequently are prescription NSAIDs dispensed and are there associated short-term (between 7-38 days of visit) safety-related outcomes?
![1]()
News
Efficacy of DOACs vs. warfarin in high-risk atrial fibrillation patients
July 25, 2019
Are the direct-acting anticoagulants (DOACs) rivaroxaban and dabigatran efficacious and safe, compared with warfarin, in elderly atrial fibrillation patients with new-onset atrial fibrillation and multiple major comorbidities?
